- Home
- Products
- Services
- Inquiry
- Career
- Resources
- About Us
- Contact Us
Catalog | BR00028167 |
Description | Pandemic coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the first step in the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The spike protein recognizes and attaches to the angiotensin-converting enzyme 2 (ACE2) receptor on the surface of type I and type II lung cells, endothelial cells, and ciliated bronchial epithelial cells. Drugs that target the interaction between SARS-CoV-2's spike protein and ACE2 may offer some protection against viral infection. |
Synonyms | SARS-CoV-2 inhibition kit, ACE2 inhibition kit, SARS TR-FRET kit, ACE2 homogenous kit |
※ It should be noted that our product is only used for research, not for clinical use.